Fukazawa, T.; Tanimoto, K.; Yamaoka, E.; Kojima, M.; Kanawa, M.; Hirohashi, N.; Hiyama, E.
Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers 2022, 14, 4732.
https://doi.org/10.3390/cancers14194732
AMA Style
Fukazawa T, Tanimoto K, Yamaoka E, Kojima M, Kanawa M, Hirohashi N, Hiyama E.
Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers. 2022; 14(19):4732.
https://doi.org/10.3390/cancers14194732
Chicago/Turabian Style
Fukazawa, Takahiro, Keiji Tanimoto, Emi Yamaoka, Masato Kojima, Masami Kanawa, Nobuyuki Hirohashi, and Eiso Hiyama.
2022. "Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy" Cancers 14, no. 19: 4732.
https://doi.org/10.3390/cancers14194732
APA Style
Fukazawa, T., Tanimoto, K., Yamaoka, E., Kojima, M., Kanawa, M., Hirohashi, N., & Hiyama, E.
(2022). Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers, 14(19), 4732.
https://doi.org/10.3390/cancers14194732